Nanoparticles in the clinic: An update.
clinic
clinical translation
clinical trials
drug delivery
nanomedicine
nanoparticles
translational medicine
Journal
Bioengineering & translational medicine
ISSN: 2380-6761
Titre abrégé: Bioeng Transl Med
Pays: United States
ID NLM: 101689146
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
05
08
2019
revised:
22
08
2019
accepted:
23
08
2019
entrez:
2
10
2019
pubmed:
2
10
2019
medline:
2
10
2019
Statut:
epublish
Résumé
Nanoparticle drug delivery systems have been used in the clinic since the early 1990's. Since that time, the field of nanomedicine has evolved alongside growing technological needs to improve the delivery of various therapeutics. Over these past decades, newer generations of nanoparticles have emerged that are capable of performing additional delivery functions that can enable treatment via new therapeutic modalities. In the current clinical landscape, many of these new generation nanoparticles have reached clinical trials and have been approved for various indications. In the first issue of
Identifiants
pubmed: 31572799
doi: 10.1002/btm2.10143
pii: BTM210143
pmc: PMC6764803
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e10143Informations de copyright
© 2019 The Authors. Bioengineering & Translational Medicine published by Wiley Periodicals, Inc. on behalf of The American Institute of Chemical Engineers.
Références
Nanomedicine. 2019 Jun;18:189-195
pubmed: 30858085
Bioeng Transl Med. 2016 Jun 03;1(1):10-29
pubmed: 29313004
Nat Rev Cancer. 2017 Jan;17(1):20-37
pubmed: 27834398
Clin Cancer Res. 2019 May 1;25(9):2685-2690
pubmed: 30541745
Int J Pharm. 2006 Jan 3;307(1):93-102
pubmed: 16303268
Cancer. 1975 Jan;35(1):98-110
pubmed: 162854
Nat Biotechnol. 2018 Sep 6;36(9):777-778
pubmed: 30188543
Nat Rev Drug Discov. 2010 Aug;9(8):615-27
pubmed: 20616808
Clin Cancer Res. 2017 Feb 15;23(4):908-917
pubmed: 27998887
Mol Pharm. 2008 Jul-Aug;5(4):496-504
pubmed: 18611037
Proc Natl Acad Sci U S A. 2019 Sep 10;116(37):18590-18596
pubmed: 31451630
J Clin Oncol. 2011 Mar 10;29(8):979-85
pubmed: 21282541
Nat Nanotechnol. 2007 Dec;2(12):751-60
pubmed: 18654426
Nat Rev Drug Discov. 2018 Aug 30;17(9):613
pubmed: 30160250
Nat Biotechnol. 2015 Sep;33(9):941-51
pubmed: 26348965
Lancet Oncol. 2019 Aug;20(8):1148-1159
pubmed: 31296491
Cancer Res. 2008 Nov 1;68(21):8643-53
pubmed: 18974103
N Engl J Med. 2018 Jul 5;379(1):11-21
pubmed: 29972753
Bioeng Transl Med. 2019 Sep 05;4(3):e10143
pubmed: 31572799
Lancet Oncol. 2018 Aug;19(8):1027-1039
pubmed: 30001990
Mol Ther. 2019 Apr 10;27(4):710-728
pubmed: 30846391
Clin Cancer Res. 2017 Aug 1;23(15):4190-4202
pubmed: 28298546
Lancet Oncol. 2017 Oct;18(10):1386-1396
pubmed: 28870611